Micralyne’s MicraFluidics technology consists of a line of standardized microfluidic process technologies to support demand from the biomedical and life-sciences industry for rapid design and deployment of integrated microfluidic-based products. The MicraFluidics technology is a functional and versatile set of standardized microfluidic processes featuring a variety of substrate options for biomedical customers such as silicon, glass and silicon-on-insulator (SOI) with design flexibility for multi-level channels, electrode patterning for dielectrophoresis and embedded sensors, and choices of glass or silicon as input and output ports. This technology has been validated in a wide range of devices such as: flow cells, biochips, lab-on-a-chip, cell sorters, separation and analysis devices, and high-pressure analytical chips.
Micralyne's MEMS Technology Platforms provide a modular approach to MEMS design and enable fast prototyping with semi-custom device implementations, and rapid manufacturing ramp-up without sacrificing product quality and consistency. Micralyne started providing standard processes and MEMS building blocks in 2006 with an effort to lower MEMS development costs and accelerate MEMS time-to-market for customers.
Micralyne will be exhibiting this wide range of technology at MD&M West, February 6-8, 2018 at Booth 771. For even more enlightenment, visit Micralyne.
Edmonton, Alberta, Canada